About Rejuvenexx
Today Rejuvenexx is known as the “Trusted Alternative to Orthopedic Surgery,” with more than 80 Rejuvenexx affiliates and over 100 highly trained physicians treating dozens of orthopedic conditions without surgery.
Our Story
Rejuvenexx founders,
Physicians in Clearwater pioneered the specialty of Interventional Orthopedics. They were the first in the world to apply stem cells from bone marrow concentrate to treat many anti-aging and injuries. Two years later, they completed a two-year, IRB-approved research study of the use of both culture-expanded and same-day stem cells to treat knee and hip arthritis and low-back degenerative disc disease.
We continuously innovate through research, development, and training. Rejuvenexx has introduced many of the processing and treatment techniques used in the field today. We have also published a large part of all research on the use of bone marrow concentrate for the treatment of orthopedic injuries.
Rejuvenexx Milestones
- 2020: Rejuvenexx publishes second randomized control trial on shoulder rotator cuff tears
- 2019: The Rejuvenexx network reaches 62
- 2016: Rejuvenexx publishes the world’s largest stem cell safety paper in any medical indication
- 2014-2017: First randomized control trial for knee arthritis completed
- 2011: The first physician joins the Rejuvenexx network
- 2009: World-class lab unveiled at Rejuvenexx headquarters, led by a doctorate-level research team publication
- 2007: Dr. Chris Centeno and Dr. John Schultz complete a two-year, IRB-approved research study of the use of both culture-expanded and same-day stem cells to treat knee and hip arthritis and low-back degenerative disc disease
- 2006: Rejuvenexx first research is published
- 2005: Rejuvenexx starts its
